PIMAVANSERIN
Clinical safety rating: safe
Animal studies have demonstrated safety
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Capsule 34 mg - Oral
Clinical note
Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can prolong the QT interval.
peripheral edema
Loading safety data…